# Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation

> **NCT01125020** · NA · UNKNOWN · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 150 (estimated)

## Conditions studied

- Liver Transplantation
- Hepatocellular Carcinoma
- Tumor Recurrence and Metastasis
- Survival
- Adjuvant Chemotherapy

## Interventions

- **DRUG:** gemcitabine and oxaliplatin
- **DRUG:** doxorubicin, 5-Fu and cisplatin

## Key facts

- **NCT ID:** NCT01125020
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-12
- **Primary completion:** 2010-05
- **Final completion:** 2010-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2010-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01125020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01125020, "Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01125020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*